Cancer patients who avoid sugar are doubling remission and survival rates

Published on May 29, 2014 at 8:54 AM · No Comments

"Fed Up," produced by Katie Couric and directed by Stephanie Soechtig, reveals secrets of the American food industry and points to direct links between our health and what we eat, with particular emphasis on sugar. The movie compares the sugar industry to the tobacco industry in terms of its effect on our health and shows how sugar can be as addictive as cocaine.

A groundbreaking seven-year study by Dr. Colleen Huber, published in the current issue of Cancer Strategies Journal, shows that cancer patients who avoid sugar are doubling remission and survival rates compared with those patients who continue to eat it. The study is ongoing, and physicians have so far treated over 300 cancer patients. Patients who completed treatment at Dr. Huber's clinic in Tempe, AZ, but continued to eat sugar, had a remission rate of 36%. On the other hand, remission rates for patients who avoided sugar were more than double that. There has never been an interventional study this large or this long, with cancer patients, indicting sugar as a major proponent in the disease and proving the success of sugar avoidance in defeating it.

"My doctors asked me to avoid all sweeteners except for stevia," says breast cancer patient Jeorgetta Douglas-Acosta.

Stevia is a plant-based sweetener that does not apparently raise blood sugar levels.

Dr. Huber's message is simple: "You are throwing gasoline on fire if you continue to eat sugar when you have cancer."

Source:

Nature Works Best

Posted in: Medical Science News | Medical Research News | Medical Condition News

Tags: , , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Olympus receives FDA clearance for Narrow Band Imaging